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Abstract
Overconsumption of free sugars, particularly from sugar-sweetened beverages (SSB), has potential negative health impacts. Implementation of a
range of public health strategies is needed to reduce intakes of free sugars, including reducing portion sizes, promoting healthier dietary choices and
reformulating foods and beverages. Although low-calorie sweeteners (LCS) are a useful tool for reducing energy intake and control glucose
response when consuming sweet foods and drinks, several opinions persist about the adverse health effects of LCS, many of which are based
on poor, little or no scientific evidence. This symposium report summarises key messages of the presentations and related discussions delivered
at a scientific symposium at the 13th European Nutrition Conference (FENS 2019). These presentations considered the scientific evidence and
current recommendations about the use and potential benefits of LCS for human health, with a particular focus on current evidence in relation
to body weight and glycaemic control. Many of the studies to date on LCS have focused on low-calorie sweetened beverages (LCSB); however,
the psychological and behavioural factors influencing consumer beliefs and consumption of LCSB need to be further explored. Current recommen-
dations for LCS use are described, including the conclusions from a recent expert consensus report identifying the challenges that remain with
LCS research. Finally, existing knowledge gaps and future actions are described, as well as two large ongoing research projects: SWITCH and
SWEET.
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Introduction
Free sugars, which encompass all monosaccharides and disac-
charides added to foods by the manufacturer, cook or con-
sumer, and sugars that are naturally present in honey,
syrups, fruit juices and fruit juice concentrates(1,2) have recently
drawn particular attention in relation to public health. The
potential negative impact of overconsumption of free sugars,
particularly from sugar-sweetened beverages (SSB), in relation
to weight gain, increased risk of type II diabetes mellitus and
tooth decay is well recognised and has informed dietary
recommendations to reduce population intakes of free sugars
to 10 or sometimes 5 % of the total energy intake(1,2).
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However, given the current high intakes of free sugars, achiev-
ing such reductions is challenging and will require implemen-
tation of a range of public health strategies, including reducing
portion sizes, promoting healthier dietary choices and refor-
mulating foods and beverages(3).
Non-nutritive sweeteners provide a desired sweet taste with-
out the addition of appreciable energy and can help maintain
the palatability of reformulated products. They can be broadly
categorised as bulk sweeteners or intense sweeteners. This
symposium report will focus on intense sweeteners, commonly
referred to as low-calorie sweeteners (LCS), and it will consider
the scientific evidence for the use and potential benefits of
LCS.
Safety evaluation
Prior to approval for use, all LCS undergo extensive safety
evaluation; the responsibility for these evaluations lies with
regulatory bodies such as the European Food Safety
Authority (EFSA), the FAO/WHO Joint Expert Committee
on Food Additives (JEFCA) and the US Food and Drug
Administration (FDA). These evaluations usually result in
the establishment of the Acceptable Daily Intake (ADI) for
each LCS. The ADI is typically calculated following the appli-
cation of large safety factors (often a factor of 100 times lower
than the ‘no observed adverse effect level’ (NOAEL) to give a
large margin of safety for even the most susceptible and sen-
sitive individuals in the population, including children and
pregnant women (Fig. 1). The ADI is often misinterpreted;
it does not represent a threshold between safe and unsafe,
but it refers to a lifetime exposure situation, not a single occa-
sion, and, therefore, infrequent consumption of levels higher
than the ADI is not a health concern(5).
At present within the EU, a total of eleven LCS are approved
for use (Table 1) in accordance with the EU Regulation 1333/
2008(6) on food additives; the use of LCS in most of the cases is
authorised in beverage or food categories with a reduction of at
least 30 % of beverage/food product energy or with no added
sugars. Replacing free sugars in SSBs with LCS is relatively
straightforward and as such offers the potential for ‘sugar-
swaps’ in SSB consumers. However, under EU Regulation
1333/2008, the permitted use of LCS depends on the food cat-
egory/categories into which the product falls, and, currently,
LCS cannot be incorporated into most of the fine baked pro-
ducts (e.g. biscuits or cakes), thus potentially limiting the oppor-
tunities for food reformulation(7). Furthermore, whilst LCS may
be a useful tool for reducing energy intake and control glucose
response when consuming sweet foods and drinks, several the-
ories persist about the adverse health effects of LCS acutely or
in the long term, many of which are based on poor, little or no
scientific evidence(3).
Recommendations from health-related organisations
In 2011, the EFSA(8) concluded that there is sufficient scien-
tific information to support the claims that intense sweeteners,
as all sugar replacers, lead to a lower postprandial rise in blood
sugar levels, if consumed in place of sugars. Public Health
England(9) recommends ‘sugar-swaps’, replacing sugary soft
drinks for diet, sugar-free or no added sugar varieties to
reduce free sugar intakes. This position has also been endorsed
by those at the British Dietetic Association,(10) who highlight
that swapping SSB for low-calorie sweetened beverages
(LCSB) is likely to be beneficial for most individuals from a
weight management, dental and diabetes perspective; however,
they highlight that healthier drink options/alternatives should
be actively encouraged (e.g. milk-based drinks) as these pro-
vide additional nutritional benefits that LCSB do not. Given
that weight management is key to managing (and preventing)
type II diabetes, the BDA also advocates the use of LCS in
adults and children, where this is in place of free sugars, noting
that in such cases LCS may be a useful means of reducing
energy intake and can help maintain a healthy body weight(10).
In 2018, Diabetes UK launched a Position Statement(11),
which concluded that low or non-caloric sweeteners are
shown to be safe and that they can be used as part of a strategy
for adults and children in the management of weight and
diabetes.
More recently, the American Diabetes Association (ADA)
also issued a new Consensus Report in 2019(12). Some of
the conclusions were that replacing added sugars with sugar
substitutes (LCS) could decrease the daily intake of carbohy-
drates and calories. These dietary changes could beneficially
affect glycaemic, body weight and cardiometabolic control.
The ADA also stated that using sugar substitutes does not
make an unhealthy choice healthy; rather, it makes such a
choice less unhealthy(12). Finally, if sugar substitutes are used
to replace caloric sweeteners, without caloric compensation,
they may be useful in reducing caloric and carbohydrate intake,
although further research is needed to confirm these
concepts(12).
The American Academy of Pediatrics has recently released a
policy statement(13) on the use of LCS in children, noting in
their key findings and recommendations that when substituted
for sugar-sweetened foods or beverages, LCS can reduce
weight gain or promote weight loss (albeit to a small extent)
in children (and adults) but recognising that data are limited.
They found no absolute contraindications to LCS use in
Fig. 1. Safety factors applied to establish the ADI. ADI, acceptable daily
intake; NOAEL, no observed adverse effect level. ADI is typically set at 1/
100th of the NOAEL (allowing for 10-fold reduction for intraspecies variation
and 10-fold reduction for interspecies variation). Source: Logue et al.(4)
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children and, for some affected by certain conditions (e.g.
obesity, type I and type II diabetes), there may be a benefit
for the use of LCS if substituted for nutritive sweeteners
(namely free sugars)(13). The only exception is the use of aspar-
tame and neotame in children with phenylketonuria (PKU),
since both these LCS contain phenylalanine which cannot be
metabolised by those with PKU(13).
Outline of this symposium report
This symposium report summarises key messages from pre-
sentations and related discussions delivered at a scientific sym-
posium at the 13th European Nutrition Conference
(Federation of Nutritional Societies (FENS 2019), which con-
sidered the scientific evidence and recommendations for the
use and potential benefits of LCS for human health, with a
particular focus on current evidence in relation to body weight
and glycaemic control. To date, many of the studies on LCS
have focused on LCSB; however, the psychological and behav-
ioural factors influencing consumer beliefs and consumption
of LCSB need to be further explored. Current recommenda-
tions for LCS use are described, including the conclusions
from a recent expert consensus report highlighting the chal-
lenges that remain with LCS research. Finally, existing knowl-
edge gaps and future actions, as well as two large ongoing
research projects: SWITCH and SWEET, are described.
LCS as a means for weight and glycemic control: outcomes of
systematic reviews and meta-analyses
Professor Anne Raben (University of Copenhagen)
started by discussing general considerations when reviewing
the LCS evidence base.
When considering reviews or original studies in health science,
it is important to remember the ‘evidence hierarchy’ with sys-
tematic reviews and meta-analyses holding the highest level, fol-
lowed by randomised controlled trials (RCT) and then by
population studies. This should always be taken into account
when studying and interpreting results from different studies.
Thus, conclusions from population studies may suffer from
the ‘reverse causality’ phenomenon whereby, for example, indi-
viduals with overweight/obesity may choose to consume LCS
foods and drinks to reduce their risk of weight gain and not
vice versa(14). Furthermore, data on glycaemic outcomes may be
confounded by changes in body weight(15). Additionally, assess-
ments of LCS intakes often consider only certain sources of LCS
(e.g. LCSB) and/or LCS as a homogenous group despite differ-
ing biological fates(5). This has the potential of not adequately
capturing intakes of individual LCS or allowing for a reliable esti-
mation of overall LCS intakes(3).
The design of RCTs should also be carefully considered. In
this aspect, especially the fixed-calorie vs the ad libitum study
design is crucial. For example, if using a fixed-calorie design,
it is not possible to show how a certain dietary component, in
this case LCS, may influence appetite, food intake or body
weight in the long term, since appetite regulation has been
taken out of the equation. In contrast, an ad libitum study design
will be able to demonstrate whether a certain LCS increases,
decreases or has no effect on appetite, food intake, glycaemic
control or body weight compared with a control situation (e.g.
sucrose or water). In this situation, a study participant will be
able to eat until satiation is reached and is not obliged to eat
a specific, predefined amount of dietary energy.
It is also important to recognise that LCS have different
chemical structures and, therefore, different metabolisms in
the human body(5). Due to these differences, LCS have very
different digestion and uptake patterns in the gut, and their
metabolic effects in the human body are, therefore, also likely
to be very different(16). Furthermore, it should be remembered
that LCS have a very high sweetness intensity and are, there-
fore, usually consumed in extremely small amounts compared
with nutritive sweeteners such as sucrose. Thus, any physio-
logical effect is likely to be minimal at most.
LCS as a means for body weight control: the evidence
Professor Raben then focused on LCS and weight control.
There have been several studies on the effectiveness of the
sweeteners, mainly aspartame, on weight control, and the
very early studies were summarised by de la Hunty et al.(17).
A study by Raben’s group using a 10-week ad libitum design
demonstrated that body weight and fat mass decreased signifi-
cantly in adults with overweight after the intake of foods and
drinks containing LCS compared with similar products
Table 1. LCS approved for use in Europe
LCS E-number Year of first EU safety evaluation and approval Sweetnessa ADI (mg/kg/BW)
Saccharin and its salts E954 1977 300–500 5
Aspartame E951 1984 180–200 40
Acesulfame-K (Ace-K) E950 1984 200 9
Cyclamates E952 1984 30 7
Thaumatin E957 1984 2000–3000 ADI not specified
Neohesperidine dihydroalcone E959 1988 1900 5
Aspartame–acesulfame salt E962 2000 350 As for aspartame and Ace-K
Sucralose E955 2000 600 15
Neotame E961 2007 7000–13 000 2
Steviol glycosides E960 2010 300 4
Advantame E969 2013 37 000 5
a Sweetness relative to sucrose; LCS, low-calorie sweeteners; ADI, Acceptable Daily Intake; BW, body weight.
Source: Adapted from Logue et al.(4)
3
journals.cambridge.org/jns
containing added sugar (sucrose), resulting in an average dif-
ference in body weight of 2⋅6 kg(18). Ten years later, a
1⋅5-year study in children (aged 4–11 years) also showed a
very clear picture(19). In the present study, participants received
250 ml/d of an LCSB or a similar SSB while at school and the
LCSBs reduced body weight gain and fat accumulation com-
pared with the sugar-containing beverages. In both these stud-
ies, the volunteers were blinded to the intervention arms.
Comprehensive reviews and meta-analyses were published a
few years later by Miller and Perez(20) and by Rogers et al.(21).
The review by Rogers et al.(21) was the first to consider both
acute and longer-term animal, human, cross-over, RCT and
cohort studies on LCS, appetite, energy intake and body weight
regulation. A meta-analysis of short-term RCTs (129 compari-
sons) showed a significantly reduced ad libitum consumption
(94 kcal) after intake of LCS v. sugar-sweetened foods or bev-
erages, with no difference when compared with water. A
meta-analysis of intervention RCTs ranging from 1 to 40
months showed that LCS v. sugar led to a reduction in body
weight of 1⋅35 kg (nine comparisons), and a similar relative
reduction in body weight v. water (three comparisons). The sys-
tematic review from Azad et al.(22) was neutral for RCTs show-
ing no benefit nor weight gain in the LCS groups compared
with the controls. Toews et al.(23) concluded from their system-
atic review, which included thirty-five observational studies, that
‘In adults, evidence of very low and low certainty from a limited
number of small studies indicated a small beneficial effect of
NSSs [i.e. LCS] on body mass index’ and ‘For all other out-
comes, no differences were detected between the use and non-
use of NSSs, or between different doses of NSSs.’
In some reviews, the different LCS have been considered
separately, which is very relevant, given that LCS have differ-
ent metabolic fates. Recent reviews on aspartame alone or ste-
viol glycosides alone showed no significant differences in body
weight between the LCS and a control or sucrose(24,25). Such
analyses are, however, hampered by the limited number of
studies, and the majority of RCTs have used a combination
of sweeteners. More recently, a 12-week RCT included four
different LCSBs (aspartame, saccharin, sucralose and rebau-
dioside A) and sucrose in a parallel-arm design including
154 participants(26). The beverages contained 400–560 kcal/d
(sucrose treatments) or <5 kcal/d (LCS treatments). The
results showed that sucrose and saccharin led to significantly
increased body weight (by 1⋅85 and 1⋅18 kg, respectively)
when compared with aspartame, rebaudioside A and sucral-
ose. The change in body weight observed was directionally
negative and significantly lower with sucralose when compared
with the three other LCS (weight difference≥ 1⋅37 kg). Energy
intake also decreased with sucralose, supporting the observed
weight loss in this group(26).
Water is generally believed to be the preferred choice over
LCS beverages. To clarify this, the role of LCS in comparison
with water was investigated in a 1-year RCT with 303 people
with overweight and obesity. All participants took part in a
12-week behavioural weight loss programme and were then
assigned to either 710 ml of water or LCSBs per day for
1 year. Convincingly, the study showed that participants drinking
LCSBs maintained more than twice the weight loss (6⋅2 kg)
compared with participants drinking water (2⋅6 kg), i.e. an
improvement of weight control with LCS compared with
water(27).
To summarise, the balance of evidence indicates that the use
of LCS in place of sugar (sucrose), in children and adults, can
lead to reduced energy intake and body weight. The current
evidence, although still limited, points to no difference or simi-
lar effects when LCS are compared with water.
LCS as a means of glycaemic control: the evidence
Professor Raben then summarised the studies on LCS and
glycemic control. In a 10-week ad libitum study, postprandial
glucose (PPG) and insulin concentrations after 10 weeks
were significantly lower after LCS vs sucrose(28). This was
also the case after adjusting for differences in body weight
changes and fasting values at week 10. After further adjust-
ing for differences in energy and sucrose intake, postprandial
insulin (PPI) was still significantly lower on the LCS diet.
The possible effect of LCS on gastrointestinal hormones
(e.g. GIP and GLP-1) was also investigated. The results
showed that postprandial GIP and GLP-1 concentrations
at 10 weeks were significantly lower after LCS compared
with sucrose, even after adjusting for differences in body
weight changes, fasting GIP and GLP-1 values, energy and
sucrose intake(28).
An RCT investigating the effect of 0, 350 or 1050 mg aspar-
tame/d in a beverage for 12 weeks reported no differences in
glucose, insulin, GLP-1 or GIP during an oral glucose tolerance
test (OGTT) in healthy, lean adults(29). A similar result for glu-
cose and insulin was seen during an OGTT after a 6-month
intake of either 1 Diet Coke, Regular Coke, water or milk(30).
In a systematic review and meta-analyses, LCS were also not
found to elevate blood glucose level – rather a gradual decline
in glucose was seen after LCS consumption(31). It was also
seen that the glycaemic impact of LCS did not differ by the
type of LCS (aspartame, saccharin, steviosides and sucralose),
but to some extent by age, body weight and diabetes state.
These latter factors are, therefore, important to consider when
comparing results from different studies on LCS.
Two other systematic reviews on LCS and glycaemia were
published in the past 5 years(32,33). Based on fourteen observa-
tional studies, LCS seemed to be related to the development of
metabolic diseases, but adiposity was often an important con-
founder. In twenty-eight clinical trials, contradictory results
were seen and, furthermore, studies were not comparable(32).
Another analysis of forty-one studies showed that some LCS
triggered physiological responses, although this was inconsist-
ent. Without co-ingestion of carbohydrates, LCS acted simi-
larly to water, and with co-ingestion of carbohydrates, LCS
reduced plasma glucose compared with sucrose(33). Very
recently, a review and meta-analyses on steviol glycosides
reported no effect of LCS on glucose(25).
Professor Raben took the opportunity to present some pre-
liminary results from a systematic review and meta-analysis of
human intervention studies. It examined the acute effect of
LCS intake on PPG and PPI responses and found that the
ingestion of LCS has no acute effects on the mean change
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in postprandial glycemic or insulinemic responses compared
with a control intervention(34).
Professor Raben concluded her presentation by looking to
the future and describing the Horizon-2020 project ‘SWEET’
(www.sweetproject.eu, 2018–2023, Grant Agreement No.
774293), which aims to dig further into the potential risks
and benefits of sweeteners and sweetness enhancers
(S&SEs). The focus is on health, obesity, safety and sustain-
ability in a multidisciplinary approach. A core part of
SWEET is a 2-year RCT across Europe, which will investigate
the effect of the prolonged use of S&SEs in a whole healthy
diet approach (foods and drinks) on diet compliance, weight
control and obesity-related risk factors (e.g. glycaemia and lipi-
demia) and safety (e.g. gut microbiota and allergenicity) in both
adults and children.
More specifically, SWEET consists of a consortium of
twenty-nine pan-European research, consumer and industry
partners. In different work packages, diverse S&SE containing
products will be developed and new databases generated
(health, technological and sweetness). The potential toxicity
and the regulatory frameworks affecting S&SE use will be
assessed. In short to medium-term studies, the impact of spe-
cific S&SEs alone or in combination pertaining to gut hor-
mone release, microbiota, central nervous system response,
eating behaviour, satiety, reward, cravings and food choice in
differing populations (gender, BMI and weight status) will be
investigated. Besides the large-scale 2-year RCT, epidemio-
logical evidence is being re-examined using multiple data sets
with up to 170,000 individuals across different European
populations. A comprehensive analysis of dietary composition
and urinary biomarkers will be done to validate self-reported
S&SE intake. The environmental, social and economic sustain-
ability of increasing the production of S&SEs through life cycle
analysis will also be investigated in the 5-year project.
Psychological and behavioural factors influencing consumer
beliefs and consumption of LCS beverages
The second speaker was Professor Jason Halford
(University of Leeds), who looked at consumer attitudes
to LCS beverages and summarised studies looking at psycho-
logical and behavioural factors influencing their consumption.
Consumption of LCS beverages (LCSB) is often higher
among adults who are overweight or have obesity, compared
with adults of a healthy weight(35). For example, studies from
the United States have shown that females who had obesity
were more likely to consume LCSBs compared with individuals
who were of a healthy weight and males(36,37). As noted previ-
ously, evidence from systematic reviews and meta-analyses sug-
gests that any association with obesity is more likely due to
reverse causality,(20,21) and a possible explanation for this associ-
ation is that individuals with overweight and obesity may utilise
LCSBs in response to their excess adiposity and/or weight gain,
rather than vice versa(38). Indeed, recent studies suggest that
LCSB consumption is tied to consumer efforts to decrease
their energy intake and, in particular, the intake of nutritive
sweeteners(39,40). Drewnowski and Rehm(41) reported an associ-
ation between the intention to lose weight and LCSB use and
found that previous weight fluctuations were a predictor of
LCSB consumption. Frequent use of LCSBs is also associated
with dietary restraint and weight concerns compared with non-
habitual use(42). Taken together, these findings are consistent
with the notion that individuals with a high BMI often use
LCSBs as a strategy to restrict energy intake in order to control
their body weight(43,44). A more detailed understanding is needed
of consumers’ attitudes and beliefs towards LCSBs. The psycho-
logical mechanisms underpinning the observed effect of LCSB
on energy intake also need to be further elucidated.
Attitudes and beliefs about LCSBs
To address current gaps in knowledge, a questionnaire on the
Attitudes and Beliefs towards LCS Beverages has recently been devel-
oped and this quantifies key factors associated with LCSBs by
measuring attitudes and beliefs associated with their consump-
tion(45). In this research, frequent consumers were defined as
individuals who consumed over 825 ml of LCSBs per day, as
determined using a self-reported online Food Frequency
Questionnaire (see Appleton and Conner(42)). Results indicated
that frequent and non-consumers of LCSBs had polarised atti-
tudes and beliefs towards LCSBs(45). Specifically, frequent consu-
mers had more positive beliefs that LCSBs were palatable and
effective in controlling their appetite and body weight in com-
parison with non-consumers. As such, beliefs about hedonic
enjoyment and health appear to influence consumer decisions
about consumption or avoidance of LCSBs. These contrasting
beliefs, and the more negative views among non-consumers,
are not surprising, given that several studies have raised public
awareness of potential adverse health effects of LCSBs,(36,46–48)
which likely discourages their consumption among some consu-
mers. The importance of overcoming such misinformation and
scepticism about LCS will be discussed in further detail later in
the paper.
In line with these findings, Catenacci et al.(49) examined the
motivations behind the consumption of LCSBs in individuals
who had successfully maintained weight loss. They found that
78 % of consumers believed that LCSBs helped them control
or reduce their total calorie consumption whilst also avoiding
weight gain. In addition, palatability was another important
factor driving the consumption of LCSBs in this sample.
This is further evidence that LCSBs may help people to con-
trol their appetite and satisfy their food cravings when dealing
with the continuous challenge of maintaining weight loss over
time. Taken together, goals concerning body image and
weight, coupled with positive hedonic reward and palatability
beliefs, appear to be significant factors in motivating the con-
sumption of LCSBs.
Psychological mechanisms underpinning the effect of LCSB on
energy intake
As noted previously, in a systematic review and meta-analysis
of short-term experimental studies, energy intake was signifi-
cantly reduced when foods or beverages containing LCS
were consumed relative to their sugar-containing
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counterparts(21). However, the psychological mechanisms that
underpin the effect of LCSB on energy intake are unclear.
One possibility is that consumers are using these beverages
as a strategy to satisfy their desire for hedonic pleasure whilst
simultaneously controlling their energy intake. As established
earlier, frequent consumers of LCSB typically have higher
levels of restrained eating, and as such, their eating behaviour
is likely to be characterised by cycles of food restriction and
disinhibited eating, ultimately making them more susceptible
to weight gain(50,51). According to the goal conflict model of
eating behaviour, individuals with high dietary restraint find
it difficult to regulate their food intake because they are jug-
gling two conflicting goals: the hedonic goal of eating enjoy-
ment whilst also satisfying the longer-term goal of weight
maintenance(52). These goals frequently conflict with each
other, because low-energy ‘diet’ foods are often less hedoni-
cally pleasing than foods of higher energy content(53).
Consumption of LCSBs may play an important role in this
context. Sweet-tasting foods and beverages are hedonically
pleasing to many people and LCSBs may, therefore, satisfy
food cravings and hedonic eating goals. In addition, due to
their very low energy content, LCSBs may simultaneously
preserve weight control goals, thereby realigning previously
conflicting goals in the goal conflict model. In this respect,
LCSBs may offer great potential as a means of managing
hedonic food motivations and cravings in individuals who
struggle with their weight.
To explore this idea, a recent study used a ‘chocolate crav-
ing’ manipulation to examine the effect of priming hedonic
eating goals on ad libitum energy intake in frequent consumers
and non-consumers of LCSBs(54). It was hypothesised that
energy intake would be greater after the hedonic eating
prime relative to a control prime in non-consumers, but that
frequent LCSB consumers would be protected from this effect
(due to their consumption of LCSBs satisfying their hedonic
eating motivations). Findings from two experiments did not
consistently support this hypothesis. However, in the second
experiment, the frequent consumers ingested fewer calories
(less energy intake) overall when LCSBs were available relative
to a condition when they were unavailable. Furthermore, when
LCSBs were unavailable, frequent consumers reported lower
perceived behavioural control (i.e. lower self-efficacy), lower
meal enjoyment and higher eating-related guilt relative to the
condition when LCSBs were available. These findings suggest
that LCSBs assist frequent consumers in exercising self-control
over food choices and weight control. This is important, given
that previous research has found that emotions, such as
eating-related guilt, can lead to negative outcomes including
selection of indulgent foods, increased food consumption
and long-term weight gain(55,56).
Interestingly, Maloney et al.(54) also found that frequent
LCSB consumers had a visual attentional bias towards images
of LCSBs, relative to water and SSB. This finding suggests that
frequent consumers view LCSBs as hedonically desirable. This
attentional bias was not evident for non-consumers, which is
consistent with research showing that individuals selectively
attend to personally relevant environmental stimuli(57,58).
Importantly, frequent consumers showed a visual preference
for LCSBs relative to sugar-containing beverages, which indi-
cates a specific bias towards LCSBs rather than a general bias
towards sweet-tasting products. This finding is contrary to the
hypothesis that LCSBs encourage a generalised preference for
sweet-tasting foods(59–61). Indeed, evidence to date suggests
that exposure to sweet taste does not promote a subsequent
preference for sweet products but, in fact, leads to a reduced
preference for sweetness in the short term(62). However, the
authors of this systematic review highlighted that the existing
evidence base is weak and that there is a need for longer-term,
adequately powered studies.
Collectively, findings to date indicate that LCSBs appear to
be fulfilling a psychological role for consumers by satisfying
their hedonic food motivations without violating dieting
goals. In doing so, LCSBs could play a meaningful role in
reducing energy intake by facilitating self-regulation in the
face of high-calorie food temptation, without the accompany-
ing caloric intake and guilt. Nevertheless, further research is
still needed to understand how these beverages affect cogni-
tions and subsequent appetitive behaviours.
Professor Halford ended his presentation by emphasising
that, whilst the beneficial effects of LCS beverages in weight
management have been reported(27,63), the effects of LCS
over longer time periods need to be further elucidated. The
SWITCH trial (Trial registration: Clinical Trials:
NCT02591134; registered: 23 October 2015) is addressing
these research gaps by exploring the longer-term effects of
LCSBs in weight management and underpinning physiological
and psychological mechanisms(64). Specifically, this ongoing
trial is assessing the effect of LCSBs, relative to water, on
both short and long-term weight management, as well as
examining several candidate behavioural and biological
mechanisms (e.g. changes in glycaemic control, fasting lipid
profiles, appetite, energy intake, food choice, mood and atti-
tudes) through which these effects may arise relative to
water. This research will provide a new and detailed under-
standing of the role that LCSBs play in weight loss and main-
tenance, particularly their psychological impact, and of the
behavioural mechanisms that mediate these effects.
Identified research gaps on LCS and suggested future actions
The final speaker was Dr Margaret Ashwell (Ashwell
Associates), who summarised the outcomes from an
Expert Consensus Workshop on LCS which was held in
November 2018(65). The aims of this workshop were to iden-
tify the reliable facts on LCS, suggest research gaps and pro-
pose future actions. During the workshop, seventeen experts
(the panel) discussed three themes identified as key to the sci-
ence and policy of LCS: (1) weight management and glucose
control; (2) consumption, safety and perception; (3) nutrition
policy. In brief, the panel agreed that the safety of LCS is
demonstrated by a substantial body of evidence reviewed by
regulatory experts. Current levels of consumption, even for
high users, are within agreed safety margins. However, the
panel identified that better risk communication is needed(65).
The panel identified research gaps for each of the three
Themes (summarised in Table 2)(65). In summary, the panel’s
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conclusions were that the substantial body of evidence con-
cerning LCS safety should be communicated in a consistent
manner. More emphasis is required on the role of LCS in help-
ing people reduce their sugar and energy intake, which is a
public health priority. The panel also felt that efforts should
be made to understand and, where possible, reconcile policy
discrepancies between organisations and reduce regulatory
hurdles that impede product development and reformulation
designed to reduce free sugars and/or energy intake. For
example, the requirement in the EU that the use of LCS in
foods/beverages in most cases should reduce the energy con-
tent of the given food/beverage by 30 % limits the options
available for a more modest reformulation or stepwise reduc-
tion in free sugar content of food/beverages.
The consensus statements and recommendations arising
from the Expert Consensus Workshop(65) should serve to
assist policymakers and other stakeholders including non-
governmental organisations (NGOs), health professionals,
research funding bodies and the food and beverage industry.
Symposium discussion
Professor Halford was asked about the different results
obtained when solid foods v. liquids were sweetened with
LCS. Do they have the same effects on appetite, intake
behaviour, etc.? He replied that this is not yet known and
drew attention to the fact that this was identified as one of
the research gaps (Table 2) in the consensus report(65).
The panel was asked about the safety of LCS for consump-
tion by pregnant women and children. The panel referred to
the decisions of the regulatory authorities and noted previously
that all currently available LCS have been extensively evaluated
for their safety and for each LCS the ADI level is a conserva-
tive estimate acceptable dietary intake over an entire lifetime
and is inclusive of all age groups and sensitive sub-
populations, including children and pregnant women(5).
One questioner referred to the recently published EPIC
cohort study(66) where a greater consumption of total,
sugar-sweetened and artificially sweetened soft drinks was
associated with a higher risk of all-cause mortality. The
panel, as well as other experts in the audience, pointed out
the flaws of observational studies and limitations of their
designs, including the potential biases in self-reported intake
assessment methods, residual confounding and reverse
causation.
Another question related to the fact that LCS are a chemically
diverse group of compounds. Do they have the same effects on
outcomes such as appetite, food intake, the gut microbiome,
weight control, etc.? Should they be examined individually or
as a group? The panel commented that often, when the out-
come under consideration is on the effects of reducing free
sugars, they are treated as a single group (without consideration
of their heterogeneous nature). However, the recent research on
the gut microbiome emphasised that, especially in this respect,
individual differences could be very important although, at typ-
ical levels of consumption, no adverse effect on human health
via gut microbiome had been established for any LCS(67,68).
Furthermore, it is worth noting that whilst a few studies have
shown changes in the gut microbiome, they have been mainly
in rodent studies (e.g. Suez et al.(69)) and have considered supra-
physiological doses with no relevance to realistic human intakes.
Also, the recent study on body weight from the group of
Richard Mattes emphasises that different LCS can have differ-
ent effects on body weight(26).
The final question was about recommendations to health-
care professionals about the use of LCS by children. The
panel referred the questioner to the recent policy statement
by the American Academy of Pediatrics with a set of recom-
mendations and guidance for paediatricians(13).
Conclusions and future research needs
Given the current public health interest on the impact of free
sugars on human health and the potential contributions that
LCS could play in achieving current recommendations for
intakes of free sugars, it is important that the research findings
from projects such as SWITCH and SWEET are fully realised
and translated into the public health space. However, it is also
important to recognise that even with a well-developed evi-
dence base, translation of any benefit of LCS into wider public
health benefits will ultimately be hampered if scepticism sur-
rounding LCS use persists within the general public, health
professionals and other key stakeholders. As highlighted by
Table 2. Consensus statements on research gaps identified by the expert
consensus panel
Theme 1 – Role of LCS in weight management and glucose control
1. What are the long-term effects of LCS on glucose tolerance, gut
function, cardiometabolic effects, gut microbiota and weight
management?
2. How are these effects altered according to personal factors, such as
age, sex, ethnicity, socio-economic status, health status, diet and
lifestyle?
3. How do these effects differ according to the dietary context (ad lib v.
weight-control diet) and form of LCS (in liquids or solids), and the type or
blend of LCS?
4. Does reducing exposure to sweetness have consequences for food
choice and intake in the medium-to-long term?
5. Can LCS help improve long-term type II diabetes management when
they are a part of standard dietary and lifestyle approaches?
Theme 2 – Consumption and safety of LCS and consumer perception
1. Which factors (including knowledge, attitudes and behaviours)
influence consumer perception of the risks and benefits of LCS
consumption? Are these the same for health professionals?
2. There is a need for in-depth data relating to the current patterns of LCS
consumption at multiple levels, and across countries and regions, to
strengthen the evidence base.
3. There is a need for more reliable measures of LCS exposure, such as
biomarkers. Further development of these and better linkage of food
composition and dietary databases are needed to help monitor the
changing use and consumption of LCS.
Theme 3 – Role of LCS in relation to nutrition policy
1. Can LCS help individuals meet the population level dietary
recommendations for reduction of sugar intake (e.g. to 5 % (average) or
10 % (for individuals))? If so, how can this be achieved?
2. How does a dietary approach that includes LCS-sweetened foods and
drinks affect dietary quality compared with low-sugar diets?
3. What are the best strategies to communicate LCS safety and efficacy to
interested parties such as health professionals and the general public?
Source: Adapted from Ashwell et al.(65)
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Ashwell et al.(65), a better understanding of the differing views
on the risks and benefits of LCS among experts, policymakers
and the general public should be prioritised. Countering mis-
information, where appropriate, is needed to ensure a balanced
reporting of the public health relevance of the totality of the
research evidence base(70). This should be done together
with public health messages which boost public understanding
of LCS, focusing on their safety and the appropriate use of
LCS within the context of a healthy diet. As a next step, the
identified research gaps (as outlined earlier) and suggested
future actions represent a blueprint for the way forward(65).
A focus on better risk communication and on the potential
benefits of LCS will assist policymakers and other stakeholders
including NGOs, health professionals, research funding bod-
ies and the food and beverage industry. This will support
wider public health strategies aimed at reducing excessive
intakes of free sugars and thereby result in positive impacts
on human health.
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